» Articles » PMID: 30775216

The Feasibility of a Modified Exclusive Endoscopic Transcanal Transpromontorial Approach for Vestibular Schwannomas

Overview
Publisher Thieme
Date 2019 Feb 19
PMID 30775216
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

 We evaluated the feasibility of an exclusive endoscopic transcanal transpromontorial approach (EETTA) for the treatment of small vestibular schwannomas (VSs) limited to the internal auditory canal (IAC), and introduced a modification without external auditory canal closure.  Between June 2016 and June 2017, seven patients with VS underwent surgery using a modified EETTA. Treatment outcomes, including efficacy of tumor resection, preservation of function, operation time, and quality of life (QOL), were evaluated.  The patients preoperatively exhibited Koos Grade I/II tumors and severe-to-profound hearing loss. Gross total resection was accomplished in all cases. There were no major complications, and all patients exhibited normal facial nerve function immediately after surgery. The mean follow-up period was 12.9 months. The operation time (average 196.3 ± 64.9 minutes) and hospitalization period (average 7.4 ± 1.0 days) were favorable. Short Form-36 scores for QOL showed unremarkable results compared with previous reports.  The modified EETTA was effective in the removal of VSs in the IAC. It can be an alternative surgical option for small VSs.

Citing Articles

Determinants of quality of life following resection of skull base tumors: a systematic review.

Sperl V, Rhomberg T, Kretschmer T Front Oncol. 2025; 14:1473261.

PMID: 39759154 PMC: 11696366. DOI: 10.3389/fonc.2024.1473261.


Clinico-Radiological Manifestations of Cochlear Schwannomas.

Hashim N, Misron K, Moon S, Noh H, Kim J, Moon I J Audiol Otol. 2024; 28(4):284-290.

PMID: 39501686 PMC: 11540968. DOI: 10.7874/jao.2024.00115.


Understanding the Molecular Mechanism of Vestibular Schwannoma for Hearing Preservation Surgery: Otologists' Perspective from Bedside to Bench.

Hosoya M, Wakabayashi T, Wasano K, Nishiyama T, Tsuzuki N, Oishi N Diagnostics (Basel). 2022; 12(5).

PMID: 35626200 PMC: 9140016. DOI: 10.3390/diagnostics12051044.

References
1.
Da Cruz M, Moffat D, Hardy D . Postoperative quality of life in vestibular schwannoma patients measured by the SF36 Health Questionnaire. Laryngoscope. 2000; 110(1):151-5. DOI: 10.1097/00005537-200001000-00027. View

2.
Neff B, Willcox Jr T, Sataloff R . Intralabyrinthine schwannomas. Otol Neurotol. 2003; 24(2):299-307. DOI: 10.1097/00129492-200303000-00028. View

3.
Falcioni M, Taibah A, Di Trapani G, Khrais T, Sanna M . Inner ear extension of vestibular schwannomas. Laryngoscope. 2003; 113(9):1605-8. DOI: 10.1097/00005537-200309000-00037. View

4.
Colletti V, Fiorino F . Middle fossa versus retrosigmoid-transmeatal approach in vestibular schwannoma surgery: a prospective study. Otol Neurotol. 2003; 24(6):927-34. DOI: 10.1097/00129492-200311000-00018. View

5.
Kennedy R, Shelton C, Salzman K, Davidson H, Harnsberger H . Intralabyrinthine schwannomas: diagnosis, management, and a new classification system. Otol Neurotol. 2004; 25(2):160-7. DOI: 10.1097/00129492-200403000-00014. View